For Clinicians

Studies Continue to Support the Therapeutic Method of the RenovoTAMP® Platform for Targeted Treatment of Pancreatic Cancer

Following are highlights of clinical data from publications, abstracts, and medical conference presentations.*

* RenovoTAMP is currently under investigation in the United States.

RenovoRx Product Instructions For Use (IFU)

For products that expire before January 1, 2023:
For products that expire after January 1, 2023: